Related Experiment Video
Updated: Jan 29, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Long-Term outcomes of children diagnosed with indeterminate colitis
Serenay Cetinoglu1, Betul Aksoy1, Ilksen Demir1
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, İzmir City Hospital, Izmir, Turkey.
Insights
Indeterminate colitis (IC) in children often presents with significant genetic mutations and requires careful monitoring for autoimmune conditions and potential reclassification to ulcerative colitis or Crohn's disease.
Area of Science:
- Pediatric gastroenterology
- Inflammatory bowel disease (IBD) research
- Autoimmune disorders in children
Background:
- Indeterminate colitis (IC) is a distinct subtype of inflammatory bowel disease (IBD).
- The clinical trajectory and outcomes of pediatric IC remain incompletely understood.
- This study aimed to define the follow-up course for children diagnosed with IC.
Purpose of the Study:
- To evaluate the clinical outcomes of pediatric indeterminate colitis (IC).
- To identify associated autoimmune conditions and genetic factors in children with IC.
- To assess the long-term disease course and potential reclassification of IC.
Main Methods:
- Retrospective review of pediatric patients diagnosed with IC between 2010 and 2022.
- Analysis of demographics, family history, laboratory markers, serology, and clinical features at diagnosis.
- Colonoscopic findings and long-term follow-up data were collected.
Main Results:
- Of 185 pediatric IBD cases, 29 (15.7%) were classified as IC.
- Over a quarter of patients (25%) had concomitant autoimmune diseases, predominantly in females.
- Pancolonic involvement occurred in 48% at diagnosis, with 13.7% developing extraintestinal manifestations.
- Genetic variants in IBD-related genes were found in 20.6% of patients.
- Two patients were later reclassified as ulcerative colitis (UC) or Crohn's disease (CD).
Conclusions:
- Genetic evaluation is recommended for pediatric IC, especially in those with co-occurring autoimmune conditions.
- Close monitoring is essential for managing potential immune-related complications and treatment success.
- Further research is needed to fully elucidate the disease course and optimize care for pediatric IC.
Background And Study Aims:
A third subtype of inflammatory bowel disease (IBD) is indeterminate colitis (IC). The clinical course of IC has not been well defined in children. The aim of this study was to evaluate the outcomes of children with IC during the follow-up period.
Patients And Methods:
All data were retrospectively reviewed in children diagnosed with IC in our center between 2010 and 2022. Patients' demographics, family history, laboratory findings at diagnosis, serologic immune markers, and clinical findings were noted.
Results:
Among 185 children diagnosed with IBD between 2010 and 2022, 29 (15.7 %) were classified as having IC. Sixteen patients (55.1 %) were male. A concomitant autoimmune disease was present in seven patients (25 %). Five of the seven patients with additional autoimmune diseases were female. Among the patients with IC, 14 (48 %) had pancolonic involvement in colonoscopy at the time of diagnosis. During follow-up, extraintestinal features of IBD manifested in four (13.7 %) patients, three (10.3 %) patients with arthritis, and one patient (3.4 %) with arthritis and psoriasis. Six patients (20.6 %) harbored pathogenic variants in IBD-related genes, including NOD2 (n = 2), IL10RA (n = 1), and Mediterranean fever (MEFV) (n = 3). Two patients were reclassified as having ulcerative colitis (UC) and Crohn's disease (CD) during follow-up.
Conclusion:
The detection of significant genetic mutations in one-fifth of the patients highlights the need for genetic evaluation, particularly in those with additional autoimmune conditions. Close monitoring of patients in this regard is crucial to ensure the success of treatment and to address any potential complications arising from immune-related issues. More comprehensive studies are essential in this context to understand the course of the disease and improve patient care.
More Related Videos
Related Concept Videos
Indeterminate Structure
Indeterminate Products
Statically Indeterminate Problem Solving
Diagnosing Acidosis and Alkalosis
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2 and...
Indeterminate Forms and L’Hôpital’s Rule
Predicting Reaction Outcomes

